Early and Effective Diagnosis of Sepsis Using Flow Cytometry

Area of Science:

• * Medical Diagnostics
• * Immunology
• * Critical Care Medicine

Background:

• * Sepsis is a life-threatening condition with high mortality and morbidity rates.
• * Early diagnosis and treatment are crucial for improving patient outcomes.
• * Current diagnostic methods like blood cultures have limitations in speed and reliability.

Purpose of the Study:

• * To evaluate the diagnostic performance of neutrophil CD64 expression using flow cytometry in sepsis patients.
• * To compare the efficacy of neutrophil CD64 with standard sepsis diagnostic tests.
• * To assess its utility in a tertiary care setting.

Main Methods:

• * Prospective analysis of 40 blood samples from suspected sepsis patients in intensive care units.
• * Measurement of neutrophil CD64 expression, C-reactive protein, procalcitonin, and complete blood count.
• * Comparison of laboratory results between sepsis and non-sepsis groups, including 10 healthy volunteers.

Main Results:

• * Neutrophil CD64 expression demonstrated the highest diagnostic value in differentiating sepsis from non-sepsis groups.
• * Achieved 100% sensitivity and high specificity (90% and 87.24%) in distinguishing between groups.
• * Showed superior diagnostic performance compared to other standard tests.

Conclusions:

• * Neutrophil CD64 expression is a sensitive, specific, and novel biomarker for early sepsis detection.
• * Flow cytometry analysis of neutrophil CD64 offers a promising tool for rapid sepsis diagnosis in critically ill patients.
• * This method can aid in timely and effective management of sepsis.